These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7851494)

  • 1. Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2.
    Schepp W; Schmidtler J; Riedel T; Dehne K; Schusdziarra V; Holst JJ; Eng J; Raufman JP; Classen M
    Eur J Pharmacol; 1994 Oct; 269(2):183-91. PubMed ID: 7851494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.
    Schepp W; Dehne K; Riedel T; Schmidtler J; Schaffer K; Classen M
    Digestion; 1996; 57(6):398-405. PubMed ID: 8913701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
    Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
    J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-1-(7-36) amide, -(1-37), and -(1-36) amide: potent cAMP-dependent stimuli of rat parietal cell function.
    Schmidtler J; Schepp W; Janczewska I; Weigert N; Fürlinger C; Schusdziarra V; Classen M
    Am J Physiol; 1991 Jun; 260(6 Pt 1):G940-50. PubMed ID: 1711782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.
    Schmidtler J; Dehne K; Allescher HD; Schusdziarra V; Classen M; Holst JJ; Polack A; Schepp W
    Am J Physiol; 1994 Sep; 267(3 Pt 1):G423-32. PubMed ID: 7943240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function.
    Gros L; Hollande F; Thorens B; Kervran A; Bataille D
    Eur J Pharmacol; 1995 Feb; 288(3):319-27. PubMed ID: 7774676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of rat parietal cell function by histamine and GLP-1-(7-36) amide is mediated by Gs alpha.
    Schmidtler J; Dehne K; Offermanns S; Rosenthal W; Classen M; Schepp W
    Am J Physiol; 1994 May; 266(5 Pt 1):G775-82. PubMed ID: 8203524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis toxin-sensitive inhibition of glucagon-like peptide 1-stimulated acid production by epidermal growth factor and transforming growth factor alpha in rat parietal cells.
    Schmidtler J; Dehne K; Schusdziarra V; Classen M; Schepp W
    Eur J Pharmacol; 1993 Jun; 246(1):59-66. PubMed ID: 8394819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor.
    Montrose-Rafizadeh C; Yang H; Rodgers BD; Beday A; Pritchette LA; Eng J
    J Biol Chem; 1997 Aug; 272(34):21201-6. PubMed ID: 9261127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4.
    Raufman JP; Singh L; Singh G; Eng J
    J Biol Chem; 1992 Oct; 267(30):21432-7. PubMed ID: 1328231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis toxin-sensitive and pertussis toxin-insensitive inhibition of parietal cell response to GLP-1 and histamine.
    Schepp W; Schmidtler J; Dehne K; Schusdziarra V; Classen M
    Am J Physiol; 1992 Apr; 262(4 Pt 1):G660-8. PubMed ID: 1348905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F; Fehmann HC; Göke R; Göke B
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39).
    Fehmann HC; Jiang J; Schweinfurth J; Wheeler MB; Boyd AE; Göke B
    Peptides; 1994; 15(3):453-6. PubMed ID: 7937318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat gastric somatostatin and gastrin release: interactions of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide.
    Eissele R; Bothe-Sandfort E; Göke B; Eng J; Arnold R; Koop H
    Life Sci; 1994; 55(8):629-34. PubMed ID: 7913983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor.
    Thorens B; Porret A; Bühler L; Deng SP; Morel P; Widmann C
    Diabetes; 1993 Nov; 42(11):1678-82. PubMed ID: 8405712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.
    Serre V; Dolci W; Schaerer E; Scrocchi L; Drucker D; Efrat S; Thorens B
    Endocrinology; 1998 Nov; 139(11):4448-54. PubMed ID: 9794451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
    López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
    J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
    Luque MA; González N; Márquez L; Acitores A; Redondo A; Morales M; Valverde I; Villanueva-Peñacarrillo ML
    J Endocrinol; 2002 Jun; 173(3):465-73. PubMed ID: 12065236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of specific binding sites for glucagon-like peptide-1 on the posterior lobe of the rat pituitary.
    Göke R; Larsen PJ; Mikkelsen JD; Sheikh SP
    Neuroendocrinology; 1995 Aug; 62(2):130-4. PubMed ID: 8584112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.